Similar articles for PMID: 14991455

Year	Number of Results
1994	2
1996	3
1998	3
1999	3
2000	3
2001	2
2002	9
2003	2
2004	3
2005	7
2006	4
2010	6
2011	3
2012	3
2013	4
2014	3
2015	3
2016	6
2017	3
2018	5
2019	4
2024	0

1

Neuroinflammatory perspectives on the two faces of Alzheimer's disease.

Eikelenboom P, van Gool WA. Eikelenboom P, et al. J Neural Transm (Vienna). 2004 Mar;111(3):281-94. doi: 10.1007/s00702-003-0055-1. Epub 2003 Dec 3. J Neural Transm (Vienna). 2004. PMID: 14991455 Review.

2

The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.

Rozemuller AJ, van Gool WA, Eikelenboom P. Rozemuller AJ, et al. Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):223-33. doi: 10.2174/1568007054038229. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 15975026 Review.

3

Neuroinflammation in Alzheimer's disease and prion disease.

Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJM, Rozemuller JM, Veerhuis R, Williams A. Eikelenboom P, et al. Glia. 2002 Nov;40(2):232-239. doi: 10.1002/glia.10146. Glia. 2002. PMID: 12379910 Review.

4

Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.

Veerhuis R, Van Breemen MJ, Hoozemans JM, Morbin M, Ouladhadj J, Tagliavini F, Eikelenboom P. Veerhuis R, et al. Acta Neuropathol. 2003 Feb;105(2):135-44. doi: 10.1007/s00401-002-0624-7. Epub 2002 Nov 6. Acta Neuropathol. 2003. PMID: 12536224

5

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.

McGeer PL, McGeer EG. McGeer PL, et al. Acta Neuropathol. 2013 Oct;126(4):479-97. doi: 10.1007/s00401-013-1177-7. Epub 2013 Sep 20. Acta Neuropathol. 2013. PMID: 24052108 Review.

6

Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease.

Eikelenboom P, van Exel E, Hoozemans JJ, Veerhuis R, Rozemuller AJ, van Gool WA. Eikelenboom P, et al. Neurodegener Dis. 2010;7(1-3):38-41. doi: 10.1159/000283480. Epub 2010 Feb 13. Neurodegener Dis. 2010. PMID: 20160456 Review.

7

Microglial activation occurs late during preclinical Alzheimer's disease.

Streit WJ, Braak H, Del Tredici K, Leyh J, Lier J, Khoshbouei H, Eisenlöffel C, Müller W, Bechmann I. Streit WJ, et al. Glia. 2018 Dec;66(12):2550-2562. doi: 10.1002/glia.23510. Epub 2018 Nov 11. Glia. 2018. PMID: 30417428

8

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.

Minter MR, Taylor JM, Crack PJ. Minter MR, et al. J Neurochem. 2016 Feb;136(3):457-74. doi: 10.1111/jnc.13411. Epub 2015 Nov 18. J Neurochem. 2016. PMID: 26509334 Free article. Review.

9

Immunological aspects of alzheimer's disease: therapeutic implications.

Hoozemans JJ, Rozemuller AJ, Veerhuis R, Eikelenboom P. Hoozemans JJ, et al. BioDrugs. 2001;15(5):325-37. doi: 10.2165/00063030-200115050-00004. BioDrugs. 2001. PMID: 11437695 Review.

10

Inflammation and Alzheimer's disease.

Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Lee YJ, et al. Arch Pharm Res. 2010 Oct;33(10):1539-56. doi: 10.1007/s12272-010-1006-7. Epub 2010 Oct 30. Arch Pharm Res. 2010. PMID: 21052932 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year